Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s):  VYYRF

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.


TSXV:VM - Post by User

Post by WarrantOfficeron Mar 04, 2024 10:45am
101 Views
Post# 35913198

Voyageur Pharmaceuticals and API Forge Alliance

Voyageur Pharmaceuticals and API Forge AllianceI was pondering Voyageur's next step in our fullerene ambitions. The PR states API is "Industry funded not for profit organization". Will the Master Service Agreement (MSA) cost Voyaguer any money or is it actually free R&D that is industry funded?  If it's free, a deserved well done to the management. Not getting to far ahead of ourselves here, it states that API will be introducing Voyageurs barium contrast products. Combined with the "Scientific Advisory Board" (SAB), if it is still functional, should open up a broad pipeline of prospective customers. Lots of hype here, time will tell if management can utilize this agreement as a springboard to becoming a profitable pharama company. 



I have attached an API link. 

Business Development & Partnership Lead Generation – API (appliedpharma.ca)



<< Previous
Bullboard Posts
Next >>